Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
10/2005
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/05/2005CN1221514C Intermediate for preparing alkyl-dihalogeno phenyl substituted keto-enol
10/04/2005US6951881 (1-substituted-indol-3-yl) alkylidenehydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
10/04/2005US6951879 Heteroaromate OSC inhibitors
10/04/2005US6951876 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
10/04/2005US6951864 4-imidazol-1-ylmethyl-pyrimidine derivatives
10/04/2005US6951857 Interleukins; cytokines; for treating eosinophil-dependent inflammatory disease/bronchial asthma
10/04/2005US6951856 Substituted pyrimidine-sulfonamide derivatives are used as endothelin receptor antagonists
10/04/2005US6951849 Psychological disorders; central nervous system disorders; schizophrenia
10/04/2005CA2257284C Remedy for autoimmune diseases
10/04/2005CA2243706C Azolyl piperazinyl phenyl oxazolidinone antimicrobials
09/2005
09/29/2005WO2005090512A1 New materials for injecting or transporting holes and organic electroluminescence devices using the same
09/29/2005WO2005090383A2 Process for preparing macrocyclic dipeptides which are suitable for the treatment of hepatitis c viral infections
09/29/2005WO2005090347A1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors
09/29/2005WO2005090340A1 Piperidine-1-carboxamide derivative
09/29/2005WO2005090339A1 New antibacterial agents
09/29/2005WO2005090338A1 Ether derivatives, their manufacture and use as pharmaceutical agents
09/29/2005WO2005090335A1 Epothilone derivatives
09/29/2005WO2005090333A1 3-‘4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
09/29/2005WO2005090332A1 Substituted quinazoline or pyridopyrimidine derivative
09/29/2005WO2005090330A1 N-piperidine derivates as ccr3 modulators
09/29/2005WO2005090328A1 Heterocyclic compound and use thereof
09/29/2005WO2005090313A1 N-(1-arylpyrazol-4l)sulfonamides and their use as parasiticides
09/29/2005WO2005090311A1 Novel heterocyclyl-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/29/2005WO2005090305A1 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension
09/29/2005WO2005089770A1 Benzodiazepines for treating or preventing or preventing rsv infection
09/29/2005WO2005089755A1 Aqueous composition comprising thiazole derivative
09/29/2005WO2005089754A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
09/29/2005WO2005089551A1 Substituted 4-(4-trifluoromethylpyrazolyl)-pyrimidines serving as herbicides
09/29/2005WO2005073224A3 Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer
09/29/2005WO2005073195A3 Hcv ns-3 serine protease inhibitors
09/29/2005WO2005070042A3 Novel chemical compounds
09/29/2005WO2005046688A3 Methods of use of thrombin receptor antagonists
09/29/2005WO2005012271A3 Process for the synthesis of biaryl oxazolidinones
09/29/2005WO2004105752A8 Substituted pyrrole derivatives as hmg-coa reductase inhibitors
09/29/2005US20050215795 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
09/29/2005US20050215784 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
09/29/2005US20050215614 Substituted indoles and their use as hcv inhibitors
09/29/2005US20050215610 Such as 3-(4-(2-[2-(3,5-Difluoro-phenyl)-acetylamino]-pentanoylamino)-imidazol-1-yl)-butyric acid methyl ester; secretase, A beta -peptide inhibitor; neurogenerative and neurological diseases: Alzheimer's disease; Notch signaling pathway inhibitor; antiinflammatory agent, asthma, autoimmune diseases
09/29/2005US20050215608 2-(pyrazol-1-yl)thiazole compounds; obesity and type II diabetes; modulators of the mitochondrial protein uncoupling protein 3 (UCP3); treating retinoid X receptor (RXR) modulated conditions; e.g. 2-(4-carboxy-5-methylpyrazol-1-yl)-4-(p-trifluoromethylphenyl)thiazole
09/29/2005US20050215605 Preterm labor, premature birth, dysmenorrhea; inhibitors of the prostaglandin F2 alpha receptor; e.g. 3-([1,1'-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide
09/29/2005US20050215603 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
09/29/2005US20050215602 E. g., 2',3',4',5,5',6,7,8,9,10-decahydro-2-(2-pyrid-3-yl-ethanediylidene-),5'-(2,2,2-trifluoroethyl)-spiro(6,9-methanobenzocyclooctene-11,3'-1,2,5-thiadiazole-1',1'-dioxide; inhibitors of gamma-secretase to modulate the processing of amyloid precursor protein (APP)
09/29/2005US20050215599 Pyrrolidine-3,4-dicarboxamide derivatives
09/29/2005US20050215594 Diabetes, obesity, urogenital disorders, cardiovascular disorders, atherosclerosis; 4-[(2R)-2-(([(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino)methyl)-3,4-dihydro-2H-chromen-6-yl]benzoic acid for example
09/29/2005US20050215593 Kaposi's sarcoma; Crohn's disease
09/29/2005US20050215587 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
09/29/2005US20050215578 Thiadiazole compounds and use thereof
09/29/2005US20050215577 Tetrahydrocarbazoles and derivatives
09/29/2005US20050215573 Novel inhibitors of glutaminyl cyclase
09/29/2005US20050215539 Derivatives of 1,2,3,5-tetrahydro-1-benzazepine, and 1,2,3,5-tetrahydro-4,1-benzoxazepine, benzthiazepine, and benzodiazepine: 4-methyl-5-(5-methyl-2-oxo-5-phenyl-1,2,3,5-tetrahydro-4,1-benzoxazepin-7-yl)thiophene-2-carbonitrile; contraceptives; hormone replacement therapy; antineoplastic agents
09/29/2005US20050214568 Aromatic terpolymers based on monomers comprising a fluorene, (9-phenyl-9-(4-bromomethylphenyl)-2,7-dibromofluorene), an imide (4-N,N-di(4-bromophenyl)-9-(4-t-butylphenyl)-1,8-naphthalimide),and a tertiary-amine (N,N'-di(4-methylphenyl)-N,N'-di(4-bromophenyl)-1,4-phenylenediamine); displays; industrial
09/29/2005US20050211293 Photoelectric transfer material, manufacturing method thereof, photoelectric transfer element and manufacturing method thereof
09/29/2005DE102004012365A1 Substituierte Dihydropyridine Substituted dihydropyridines
09/29/2005DE102004011705A1 Substituierte 4-(4-Trifluormethylpyrazolyl)-Pyrimidine Substituted 4- (4-Trifluormethylpyrazolyl) -pyrimidines
09/29/2005CA2560286A1 Substituted quinazoline or pyridopyrimidine derivative
09/29/2005CA2560199A1 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension
09/29/2005CA2559553A1 Ether derivatives, their manufacture and use as pharmaceutical agents
09/29/2005CA2559097A1 Substituted 4-(4-trifluoromethylpyrazolyl)-pyrimidines serving as herbicides
09/29/2005CA2558058A1 N-piperidine derivates as ccr3 modulators
09/29/2005CA2557929A1 Benzodiazepines for treating or preventing or preventing rsv infection
09/29/2005CA2557730A1 Novel heterocyclyl-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/29/2005CA2557054A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
09/29/2005CA2556917A1 Process for preparing macrocyclic compounds
09/29/2005CA2556915A1 Epothilone derivatives
09/29/2005CA2554610A1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors
09/28/2005EP1578885A2 Organic electroluminescent element
09/28/2005EP1578745A1 Benzofuran derivates, process for their preparation and intermediates thereof
09/28/2005EP1578743A2 Antibacterial agents
09/28/2005EP1578736A1 Mek inhibiting oxa- and thia-diazol-2-yl-phenylamine derivatives
09/28/2005EP1578732A2 Pyrimidine derivatives for the treatment of abnormal cell growth
09/28/2005EP1578723A2 Process for the preparation of oxazolidinones and method of use thereof
09/28/2005EP1578715A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
09/28/2005EP1578423A1 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
09/28/2005EP1578341A2 Modulation of ccr4 function
09/28/2005EP1373258B1 Ether derivatives useful as inhibitors of pde4 isozymes
09/28/2005EP1299365B1 2-aminothiazoline derivatives and their use as no-synthase inhibitors
09/28/2005EP1286987B1 Heterocyclic hydrazones for use as anti-cancer agents
09/28/2005EP1243583B1 Heterocyclic compounds having sulfonamide groups
09/28/2005EP1165510B1 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
09/28/2005EP1086099B1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
09/28/2005CN1675220A Epothilone derivatives
09/28/2005CN1675203A Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
09/28/2005CN1675201A N-substituted piperidine derivatives as serotonin receptor agents
09/28/2005CN1675197A 2-thio-substituted imidazole derivatives and their use in pharmaceutics
09/28/2005CN1675196A Indole derivatives or benzimidazole derivatives for modulating IKB kinase
09/28/2005CN1675195A Inhibitors of tyrosine kinases
09/28/2005CN1675189A Novel use of benzothiazole derivatives
09/28/2005CN1675188A 噻唑衍生物 Thiazole derivatives
09/28/2005CN1674906A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors
09/28/2005CN1674895A Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
09/28/2005CN1674892A Hetero biaryl derivatives as matrix metalloproteinase inhibitors
09/28/2005CN1673221A Isoxazoline derivative and herbicide comprising the same as active ingredient
09/28/2005CN1220683C Acyl derivatives for treating VLA-4 related disorders
09/27/2005US6949580 Anticancer agents; restenosis; antiinflammatory agents; cardiovascular disorders
09/27/2005US6949578 useful in selectively inhibiting or antagonizing the alpha v beta 3 and/or alpha v beta 5 integrins; treatment of osteoporosis, humoral hypercalcemia of malignancy, Paget's disease, tumor metastasis, solid tumor growth (neoplasia), angiogenesis
09/27/2005US6949571 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof.
09/27/2005US6949566 For use as metalloproteinase inhibitors
09/27/2005US6949551 Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides
09/27/2005US6949546 N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity
1 ... 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 ... 628